# Epocal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epocal

- Industry: Healthcare
- Headquarters: Ottawa, Canada
- Website: www.epocal.com
- Total disclosed funding: $35M
- Latest round: Series C (Apr 19, 2007)
- Investors on record: 3

## About

Epocal Inc. specializes in rapid, point-of-care blood analysis solutions designed to enhance clinical workflows. Their innovative epoc® system delivers lab-quality results in under a minute, thus improving patient management efficiency in healthcare settings.Founded in 2001, Epocal Inc. is based in Ottawa, Canada and focuses on the development of blood analysis technology. In February 2013, the company was acquired by Alere Medical, Inc. for USD 166 mn, which included milestone-based funding of USD 15 mn and potential future awards of USD 75.5 mn upon achieving specific goals. The company has completed a total of 7 deals, marking a significant investment interest in its technology.Epocal Inc. is known for its epoc® Blood Analysis System, a handheld and wireless device that enables comprehensive blood analysis at the patient’s side. This system uses a single, room temperature-stable test card to provide lab-quality results in less than a minute, facilitating efficient clinical workflows for healthcare professionals across hospitals, clinics, and healthcare providers, primarily in North America and Europe.Epocal Inc. generates revenue through direct sales of its epoc® Blood Analysis System and associated consumables, including necessary test cards for blood analyses. The company primarily operates on a B2B model, where healthcare facilities acquire the equipment and consumables for diagnostic processes. The revenue stream is bolstered by service agreements and maintenance contracts to ensure device efficiency, with the pricing structure reflecting the system's capabilities, although specific pricing details remain proprietary.Following the acquisition by Alere Inc., Epocal plans to leverage the recent funding to enhance its product offerings and expand into new markets. The company aims to innovate and release upgraded versions of its epoc® system while targeting expansion into additional regions in North America and Europe by 2015. The funding will support the development of new products and further integration of its technology into healthcare workflows.

## Funding rounds

- Series C, Apr 19, 2007, $31M — Genesys Capital Management, NexPoint Asset Management
- Series B, Apr 7, 2005, $4.1M — Genesys Capital Management
- Seed, Nov 1, 2001 — Covington

## Investors

- Covington (https://capitalatlas.ai/funds/covington) — Seed
- Genesys Capital Management (https://capitalatlas.ai/funds/genesys-capital-management) — Series B, Series C
- NexPoint Asset Management (https://capitalatlas.ai/funds/nexpoint-asset-management) — Series C